Galmed Pharmaceuticals
GLMD
#10337
Rank
C$3.45 M
Marketcap
$2.08
Share price
-8.80%
Change (1 day)
-59.38%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$9.08

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$9.62. In 2022 the company made an earnings per share (EPS) of -$15.20 an increase over its 2021 EPS that were of -$28.47.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$9.08-40.28%
2022-$15.20-46.62%
2021-$28.47-2.22%
2020-$29.1139.18%
2019-$20.9270.18%
2018-$12.29-41.84%
2017-$21.13-34.23%
2016-$32.1356.84%
2015-$20.499.2%
2014-$18.76-53.43%
2013-$40.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.85-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.78-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.08-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.39-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA